![](https://www.practical-patient-care.com/wp-content/themes/goodlife-wp-B2B/images/WhitePaper_Default_icon.png)
Therapeutic drug monitoring of TNF inhibitors
By R-Biopharm
The TAXIT study by KU Leuven demonstrated the positive effect of the therapeutic drug monitoring of infliximab with regards to cost savings and therapy optimisation. R-Biopharm develops products and processes to optimise TDM.
![](https://www.practical-patient-care.com/wp-content/themes/goodlife-wp-B2B/images/WhitePaper_Default_icon.png)